Article
Decreased Usage of Specific Scrib Exons Defines a More Malignant Phenotype of Breast Cancer With Worsened Survival.
EBioMedicine - 1 Jun 2016
Metodieva Gergana, Adoki Samson, Lausen Berthold, Metodiev Metodi V
Abstract excerpt
SCRIB is a polarity regulator known to be abnormally expressed in cancer at the protein level. Here we report that, in breast cancer, an additional and hidden dimension of deregulations exists: an unexpected SCRIB exon usage pattern appears to mark a more malignant tumor phenotype and significantly correlates with survival. Conserved exons encoding the leucine-rich repeats tend to be overexpressed while others...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
